Edwards Lifesciences (EW) Gross Profit Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 8.95% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 4.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.36% |
| Mar 31, 2026 | 9.03% |
| Dec 31, 2025 | 32.38% |
| Sep 30, 2025 | 4.28% |
| Jun 30, 2025 | 2.45% |
| Mar 31, 2025 | 2.17% |
| Dec 31, 2024 | 2.34% |
| Sep 30, 2024 | 3.01% |
| Jun 30, 2024 | 1.64% |
| Mar 31, 2024 | 4.15% |
| Dec 31, 2023 | 4.28% |
| Sep 30, 2023 | 4.91% |
| Jun 30, 2023 | 14.50% |
| Mar 31, 2023 | 4.74% |
| Dec 31, 2022 | -15.87% |
| Sep 30, 2022 | 9.94% |
| Jun 30, 2022 | 12.16% |
| Mar 31, 2022 | 11.03% |
| Dec 31, 2021 | 11.15% |
| Sep 30, 2021 | 13.57% |